Rathmell: A tough budget is an opportunity to make sure NCI is “doing what is best for the American public”

The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic

“I don’t think any good cancer center director would be worth their weight in salt if they weren’t worried about something at night,” said Mark Evers, director of University of Kentucky Markey Cancer Center.

July 18, 2025

Vol.51 No.28

By Paul Goldberg and Katie Goldberg

Funding Opportunities

Lung Cancer Research Foundation announces $3.75 million in research funding opportunities

The Lung Cancer Research Foundation announced funding opportunities to advance lung cancer research, including two new Team Science awards and an Early Career Investigator award.

July 18, 2025

Vol.51 No.28

Clinical Roundup

Enrollment begins in NCI’s Vanguard study focused on defining benefits of MCD tests

NCI has initiated a pilot study to address the feasibility of using multi-cancer detection, or MCD, tests in future randomized controlled trials.

July 18, 2025

Vol.51 No.28

Cancer Policy

Supreme Court lifts lower-court freeze on RIFs

The U.S. Supreme Court has temporarily lifted a lower court’s freeze on the Trump administration’s reductions in force, or RIFs, freeing the government to continue their large-scale restructuring of the federal government.

July 11, 2025

Vol.51 No.27

By Jacquelyn Cobb

Funding Opportunities

NCI, SITC immunotherapy fellowship calls for applications

NCI and the Society for Immunotherapy of Cancer are accepting applications for a one-year fellowship program beginning in July 2026.

July 11, 2025

Vol.51 No.27

Podcast

In The Headlines: George Weiner on the importance of patients’ stories

In last week’s issue of The Cancer Letter, the cover story featured Col. Susan Fondy, an Army veteran and stage 3 breast cancer survivor, who is now living with lymphedema. Fondy is now a lymphedema advocate, working to prevent further cuts to the already-sparse funding for the disease.

July 09, 2025

Vol.51 No.26

Rathmell: A tough budget is an opportunity to make sure NCI is “doing what is best for the American public”

YOU MAY BE INTERESTED IN

The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic

Lung Cancer Research Foundation announces $3.75 million in research funding opportunities

Enrollment begins in NCI’s Vanguard study focused on defining benefits of MCD tests

Supreme Court lifts lower-court freeze on RIFs

NCI, SITC immunotherapy fellowship calls for applications

In The Headlines: George Weiner on the importance of patients’ stories

Renew today!

Subscriber content

Never miss an issue!

Login

Rathmell: A tough budget is an opportunity to make sure NCI is “doing what is best for the American public”

YOU MAY BE INTERESTED IN

The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentumAs oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic

Lung Cancer Research Foundation announces $3.75 million in research funding opportunities

Enrollment begins in NCI’s Vanguard study focused on defining benefits of MCD tests

Supreme Court lifts lower-court freeze on RIFs

NCI, SITC immunotherapy fellowship calls for applications

In The Headlines: George Weiner on the importance of patients’ stories

Never miss an issue!

Login

The Directors: Mark Evers and Steven Libutti on riding out the tempest—and maintaining research momentum
As oncology braces for funding, Medicaid cuts, these two directors tell young investigators not to panic